PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Mayo researchers pinpoint how 1 cancer gene functions

A factor in multiple myeloma, and other conditions

2011-02-03
(Press-News.org) ROCHESTER, Minn. -- For several decades, researchers have been linking genetic mutations to diseases ranging from cancer to developmental abnormalities. What hasn't been clear, however, is how the body's genome sustains such destructive glitches in the first place. Now a team of Mayo Clinic scientists and collaborators provide an unprecedented glimpse of a little-understood gene, called MMSET, revealing how it enables disease-causing mutations to occur. The findings appear in the current issue of Nature.

"MMSET had been known for many years, and had been shown to be mutated in several diseases, but its function had never quite been pinpointed," says lead author Zhenkun Lou, Ph.D., Mayo Clinic pharmacologist and senior author of the study.

The researchers found that normally-functioning MMSET is usually helpful. It plays a restorative role within the genome, recruiting proteins like p53-binding protein 1 to repair breaks that occur in DNA and to maintain genetic stability. But when MMSET malfunctions, the protective pathway falls short, and a cascade of mutations take place that can lead to disease processes.

"It was not clear before the study how p53-binding protein 1 was targeted to sites of DNA damage. We found MMSET regulates this critical pathway," Dr. Lou says. "But when the gene is impaired, cells don't have the correct response to DNA damage." Misregulation of MMSET has been implicated in cancers like the plasma cell cancer multiple myeloma as well as the inherited disorder of severe retardation known as Wolf-Hirschhorn syndrome, even though the MMSET mutation looks different in the two diseases.

While the study answers a long baffling mystery about the function of the gene, it also suggests avenues for new therapeutic approaches for several disorders, notes Dr. Lou. One possible route for clinical investigation is for patients with MMSET mutations, which keep DNA from undergoing efficient repair, to be given treatment that will help minimize genetic damage. For instance, patients with defects in DNA damage-maintenance machinery often succumb to neurological disorders (e.g., ataxia telangiectasia and Wolf-Hirschhorn syndrome), since neurons are very sensitive to DNA damage spontaneously occurring in cells. These patients could be given anti-oxidative treatment to help maintain the health of DNA and preserve neurons.

The finding also suggests new thinking about treating certain cancers. MMSET protein has been found in abundance in hard-to-treat malignancies such as multiple myeloma and glioblastoma, a devastating brain tumor.

"It may be that these cancers don't respond well to chemotherapy treatment, which works by interrupting DNA, because the [MMSET producing] cancer cells are more efficient at repairing themselves," Dr. Lou says. Dr. Lou is currently working with the National Institutes of Health-Mayo Brain Tumor SPORE (Specialized Program of Research Excellence) to investigate whether MMSET levels will be a biomarker to guide glioblastoma treatment. Future investigations may involve inhibiting MMSET in proliferating cancer cells, which may make cancers more responsive to cell-killing chemotherapies.

###

The study was funded by The Richard M. Schulze Family Foundation, the National Institutes of Health, the American Cancer Society, Mayo Clinic, and a Siteman Career Award in Breast Cancer Research. Co-authors include Huadong Pei, Ph.D.; Kuntian Luo, Ph.D.; Yuxin Qin, Ph.D.; Marta Chesi, Ph.D.; P. Leif Bergsagel, M.D.; and Liewei Wang, M.D., Ph.D., all of Mayo Clinic; and Lindsey Zhang, Frances Fei, and Zhongsheng You, Ph.D., of Washington University, St. Louis.

About Mayo Clinic

Mayo Clinic is a nonprofit worldwide leader in medical care, research and education for people from all walks of life. For more information, visit www.mayoclinic.org/about/ and www.mayoclinic.org/news.

END



ELSE PRESS RELEASES FROM THIS DATE:

Flash of fresh insight by electrical brain stimulation

2011-02-03
Are we on the verge of being able to stimulate the brain to see the world anew - an electric thinking cap? Research by Richard Chi and Allan Snyder from the Centre for the Mind at the University of Sydney suggests that this could be the case. They found that participants who received electrical stimulation of the anterior temporal lobes were three times as likely to reach the fresh insight necessary to solve a difficult, unfamiliar problem than those in the control group. The study published on February 2 in the open-access journal PLoS ONE. According to the authors, ...

Children's genes influence how well they take advantage of education

2011-02-03
New research from the Twins Early Development Study at King's College London Institute of Psychiatry (IoP), published in PLoS ONE on February 2nd, shows that measures used to judge the effectiveness of schools are partly influenced by genetic factors in students. The study, funded by the Medical Research Council (MRC), was conducted by scientists in the UK at the MRC Social, Genetic and Developmental Psychiatry Centre, King's IoP, and in the US at the University of New Mexico. The assumption behind measures of school effectiveness is that changes in student performance ...

Multiple genome sequencing yields detailed map of structural variants behind our genetic differences

2011-02-03
Chestnut Hill, Mass. (2/3/2011) – Analyzing billions of pieces of genetic data collected from people around the world, Boston College biologist Gabor Marth and his research team are playing an integral role in the global effort to sequence 1000 genomes and move closer to understanding in fine detail how genetics influence human health and development. The most comprehensive map to date of genomic structural variants – the layer of our DNA that begins to distinguish us from one another – has been assembled by analyzing 185 human genomes, Marth and co-authors from the 1000 ...

Researchers identify molecular predictor of metastatic prostate cancer

2011-02-03
BOSTON—Prostate tumors that carry a "signature" of four molecular markers have the potential to become dangerously metastatic if not treated aggressively, researchers at Dana-Farber Cancer Institute report in a study published online today by the journal Nature. The discovery lays the groundwork for the first gene-based test for determining whether a man's prostate cancer is likely to remain dormant within the prostate gland, or spread lethally to other parts of the body. By analyzing prostate cancer tissue from hundreds of men participating in a national health study, ...

Schizophrenia gene mutation found; target for new drugs

Schizophrenia gene mutation found; target for new drugs
2011-02-03
In a major advance for schizophrenia research, an international team of scientists, led by Jonathan Sebat, PhD, assistant professor of psychiatry and cellular and molecular medicine at the University of California, San Diego School of Medicine, has identified a gene mutation strongly linked to the brain disorder – and a signaling pathway that may be treatable with existing compounds. The work poses significant and immediate implications for neurobiology and the treatment of schizophrenia because the gene identified by the researchers is an especially attractive target ...

Cell reprogramming leaves a 'footprint' behind

Cell reprogramming leaves a footprint behind
2011-02-03
LA JOLLA, CA—Reprogramming adult cells to recapture their youthful "can-do-it-all" attitude appears to leave an indelible mark, found researchers at the Salk Institute for Biological Studies. When the team, led by Joseph Ecker, PhD., a professor in the Genomic Analysis Laboratory, scoured the epigenomes of so-called induced pluripotent stem cells base by base, they found a consistent pattern of reprogramming errors. What's more, these incompletely or inadequately reprogrammed hotspots are maintained when iPS cells are differentiated into a more specialized cell type, ...

Why folic acid may prevent a first heart attack, but not a second

2011-02-03
A perplexing medical paradox now has an explanation according to research undertaken at Barts and The London School of Medicine and Dentistry and published in the current issue of the Public Library of Science. The paradox is that taking folic acid, a B vitamin, lowers homocysteine in the blood which, epidemiological evidence indicates, should lower the risk of heart attack, but clinical trials of folic acid have not shown the expected benefit. The explanation is surprisingly simple; lowering homocysteine prevents platelets sticking, which stops blood clots…something ...

Could the humble sea cucumber save our seas?

2011-02-03
It may look like an over-grown slug, but scientists at Newcastle University believe the sea cucumber could play a vital role in the fight to save our seas - and become an unusual addition to British gourmet food. Not only is this salty Asian delicacy a rich source of nutrients, it is also an important part of the marine ecosystem. Much like worms working soil in a garden, sea cucumbers are responsible for cleaning up the sea bed - moving, consuming and mixing marine sediments. Used widely in Chinese medicine and cuisine, sea cucumbers are also a rich source of glucosamine ...

Giant virus, tiny protein crystals show X-ray laser's power and potential

Giant virus, tiny protein crystals show X-ray lasers power and potential
2011-02-03
Menlo Park, Calif. — Two studies published in the February 3 issue of Nature demonstrate how the unique capabilities of the world's first hard X-ray free-electron laser—the Linac Coherent Light Source, located at the Department of Energy's SLAC National Accelerator Laboratory—could revolutionize the study of life. In one study, an international research team used the LCLS to demonstrate a shortcut for determining the 3-D structures of proteins. The laser's brilliant pulses of X-ray light pulled structural data from tiny protein nanocrystals, avoiding the need to use ...

Vegans' elevated heart risk requires omega-3s and B12

2011-02-03
People who follow a vegan lifestyle — strict vegetarians who try to eat no meat or animal products of any kind — may increase their risk of developing blood clots and atherosclerosis or "hardening of the arteries," which are conditions that can lead to heart attacks and stroke. That's the conclusion of a review of dozens of articles published on the biochemistry of vegetarianism during the past 30 years. The article appears in ACS' bi-weekly Journal of Agricultural and Food Chemistry. Duo Li notes in the review that meat eaters are known for having a significantly higher ...

LAST 30 PRESS RELEASES:

Label distribution similarity-based noise correction for crowdsourcing

The Lancet: Without immediate action nearly 260 million people in the USA predicted to have overweight or obesity by 2050

Diabetes medication may be effective in helping people drink less alcohol

US over 40s could live extra 5 years if they were all as active as top 25% of population

Limit hospital emissions by using short AI prompts - study

UT Health San Antonio ranks at the top 5% globally among universities for clinical medicine research

Fayetteville police positive about partnership with social workers

Optical biosensor rapidly detects monkeypox virus

New drug targets for Alzheimer’s identified from cerebrospinal fluid

Neuro-oncology experts reveal how to use AI to improve brain cancer diagnosis, monitoring, treatment

Argonne to explore novel ways to fight cancer and transform vaccine discovery with over $21 million from ARPA-H

Firefighters exposed to chemicals linked with breast cancer

Addressing the rural mental health crisis via telehealth

Standardized autism screening during pediatric well visits identified more, younger children with high likelihood for autism diagnosis

Researchers shed light on skin tone bias in breast cancer imaging

Study finds humidity diminishes daytime cooling gains in urban green spaces

Tennessee RiverLine secures $500,000 Appalachian Regional Commission Grant for river experience planning and design standards

AI tool ‘sees’ cancer gene signatures in biopsy images

Answer ALS releases world's largest ALS patient-based iPSC and bio data repository

2024 Joseph A. Johnson Award Goes to Johns Hopkins University Assistant Professor Danielle Speller

Slow editing of protein blueprints leads to cell death

Industrial air pollution triggers ice formation in clouds, reducing cloud cover and boosting snowfall

Emerging alternatives to reduce animal testing show promise

Presenting Evo – a model for decoding and designing genetic sequences

Global plastic waste set to double by 2050, but new study offers blueprint for significant reductions

Industrial snow: Factories trigger local snowfall by freezing clouds

Backyard birds learn from their new neighbors when moving house

New study in Science finds that just four global policies could eliminate more than 90% of plastic waste and 30% of linked carbon emissions by 2050

Breakthrough in capturing 'hot' CO2 from industrial exhaust

New discovery enables gene therapy for muscular dystrophies, other disorders

[Press-News.org] Mayo researchers pinpoint how 1 cancer gene functions
A factor in multiple myeloma, and other conditions